3 Key Trends Shaping Our Industry: Contract Pharma Thought Leadership Feature with Eleanor Row
What are the "3 Key Trends" that are shaping the CDMO industry in 2023 and beyond?
From integrated drug development services to sterile drug manufacturing, our Executive Director of Commercial, Dr Eleanor Row, touches on it all in Contract Pharma's latest thought leadership article "3 Key Trends that are Shaping the CDMO Industry".
Traditionally, the CDMO/CRO industry has been highly siloed. Mainly this has been down to a large number of organizations outsourcing or operating almost completely in isolation. At Quotient Sciences we see substantial benefits around forming collaborations with other service providers in the marketplace, such as Charles River. With collaboration in place alongside our end-to-end integrated programs, we see more informed decision-making, reduced risk, condensed timelines and reduced costs.
Read more from what Eleanor shared in "3 Key Trends" on the Contract Pharma website.